XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.10.0.1

REVERSE MERGER (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
REVERSE MERGER [Abstract] |
Business Acquisition, Pro Forma Information | The following unaudited pro forma information presents the Company's financial results as if the acquisition of Transgenomic had occurred on January 1, 2017 and combines Transgenomic’s unaudited condensed consolidated statement of operations for the three and six months ended June 30, 2017 with Precipio’s unaudited condensed statement of operations for the three and six months ended June 30, 2017: ﻿ ﻿
﻿ |  |  |  |  |  |
﻿Dollars in thousands, except per share amounts |  | June 30, 2017
﻿ |  |  | Three Months Ended |  |  | Six Months Ended
﻿Net sales |  | $ | 565 |  | $ | 1,472
﻿Net loss available to common stockholders |  |  | (11,086) |  |  | (13,864)
﻿Loss per common share |  | $ | (1.73) |  | $ | (2.16)
﻿

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration